Note: Ingredients listed on restricted chemical lists
EC/CAS
265-157-1/64742-54-7
Name of the chemical
Distillates (petroleum), hydrotreated heavy paraffinic
Concentration
35 - 50
EC/CAS
310-154-3/121158-58-5
Name of the chemical
Phenol, dodecyl-, branched
Concentration
0,1 - 1
General Information
Version
3.0
Revision date
2024-06-25
Product name
Eurol Additive-S Engine
Emergency telephone
+31 88 303 7598, +353 1 809 2566, +353 1 809 2166, +356 2545 6508, 0344 892 0111, 0845 4647
Icons in SDS
Company Information
company name
Eurol B.V
e-mail address of the competent person responsible for the Safety Data Sheet
reach@eurol.com
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice.
2.2 Label elements
Labelling
Precautionary statements
P102 - Keep out of reach of children.
Supplemental label elements
EUH210 - Safety data sheet available on request. Child-resistant fastening : Not applicable Tactile warning : Not applicable
2.3 Other hazards
Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Substance(s) not meeting the PBT criteria of REACH phenol, dodecyl-, branched (121158-58-5) regulation, in accordance with Annex XIII Substance(s) not meeting the vPvB criteria of REACH phenol, dodecyl-, branched (121158-58-5) regulation, in accordance with Annex XIII The mixture contains substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Component Substance(s) included in the list established in phenol, dodecyl-, branched (121158-58-5) accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605